Description
5-Amino-1MQ | 50 mg Capsules (60ct)
Advanced NNMT Inhibitor for Laboratory Research. This small-molecule compound is provided in 50 mg concentrations, specifically encapsulated for the investigation of nicotinamide N-methyltransferase (NNMT) pathways and their impact on cellular energy and metabolism.
Technical Specifications
-
Active Molecule: 5-Amino-1-methylquinolinium
-
Concentration: 50 mg per unit
-
Quantity: 60 Capsules
-
Molecular Target: Nicotinamide N-methyltransferase (NNMT)
-
Format: Oral-stable research grade
Primary Research Areas
-
NAD+ Pathway Modulation: Studies focusing on how NNMT inhibition preserves NAD+ availability within cellular models.
-
Mitochondrial Biogenesis: Evaluation of the molecule’s role in enhancing mitochondrial efficiency and energy production.
-
Metabolic Signaling: Research regarding the regulation of adipocyte (fat cell) metabolism and energy expenditure.
-
Sirtuin Activation: Investigation into the secondary activation of SIRT1 and its influence on longevity-related pathways.
Strict Compliance Disclaimer
This product is intended for LABORATORY RESEARCH USE ONLY. It is not for human or animal consumption. This compound is not a drug, supplement, or food product. It is strictly prohibited for use in the diagnosis, cure, mitigation, treatment, or prevention of any disease. All research must be conducted by qualified professionals using appropriate safety protocols.
